Solara Active Pharma Sciences has informed that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, May 15, 2025, to consider and approve, the audited financial results (standalone and consolidated) of the Company for the Quarter and year ended March 31, 2025, amongst other matters. In accordance with the Company's Code of Conduct to regulate, monitor and report trading by insiders, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from April 1, 2025, till 48 hours after the announcement of financial results i.e., up to May 17, 2025.
The above information is a part of company’s filings submitted to BSE.
